Clinical Trial Update: Setrusumab vs Placebo for Osteogenesis Imperfecta [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates a Phase 2/Phase 3 study of Setrusumab versus Placebo for Osteogenesis Imperfecta is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Setrusumab (setrusumab)

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Osteogenesis Imperfecta | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING